BIIB

Biogen Inc.

Healthcare · in the S&P 500

📍 Cambridge, United States · See it on the company map

The shape of the figures

Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.

Drag to turn the shape. Tap or point at a dot to read the figure behind it.

The figures and what each one means are below. A hollow dot means the company doesn't report that figure.

Figures from the annual reports are unavailable right now — please try again in a minute.

Key figures, against the S&P 500

Figures as of 9 Nov 2026, refreshed weekly

Each bar places this company among the S&P 500 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.

Valuation

P/E ratio?

110.0x

The share price is 110 times the last twelve months' earnings per share.

lowesthigher than 96% of the S&P 500highest

P/E on average earnings?

21.1x

The share price is 21.1 times earnings per share averaged over recent years.

lowesthigher than 29% of the S&P 500highest

Price / book

2.0x

The market values the company at 2 times the accounting value of its equity.

lowesthigher than 27% of the S&P 500highest

EV / EBIT?

23.7x

The company's value including its debt is 23.7 times its operating profit.

lowesthigher than 57% of the S&P 500highest

Free cash flow yield?

2.2%

Free cash flow equals 2.2% of the company's market value.

lowesthigher than 26% of the S&P 500highest

Profitability

Return on equity?

1.9%

Each 100 of shareholders' money produced 1.9 of net profit.

lowesthigher than 6% of the S&P 500highest

Return on assets?

4.9%

Each 100 of assets produced 4.9 of net profit.

lowesthigher than 42% of the S&P 500highest

Return on invested capital

6.2%

Each 100 invested by lenders and owners produced 6.2 of profit.

lowesthigher than 24% of the S&P 500highest

Operating margin?

18.4%

Of every 100 in sales, 18.4 was left as operating profit.

lowesthigher than 50% of the S&P 500highest

Debt

Debt / equity?

41.2%

Total debt equals 41% of shareholders' equity.

lowesthigher than 26% of the S&P 500highest

Net debt / EBITDA?

2.0x

Net debt equals 2 years of operating earnings (EBITDA).

lowesthigher than 55% of the S&P 500highest

Interest cover

6.8x

Operating profit was 6.8 times the interest bill.

lowesthigher than 46% of the S&P 500highest

Growth

Revenue growth

-0.0%

Latest revenue is 0% below the average of earlier reported years.

lowesthigher than 16% of the S&P 500highest

Earnings growth

-33.6%

Latest net profit is 33.6% below the average of earlier reported years.

lowesthigher than 15% of the S&P 500highest

⚠️ Not financial advice

This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.

This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.